Navigating disruptions on the road to a resilient cell and gene therapy outbound supply chain
Description
In this podcast, we explore the latest advancements in the cell and gene therapy (CGT) supply chain, focusing on the newly released CGT outbound supply chain tool. We had the pleasure of speaking with two key contributors, Maria and Kelly, who shared their insights on the tool’s usability and its effectiveness in educating stakeholders about the complexities of the CGT supply chain.
As the tool continues to evolve, Maria and Kelly also discuss the potential disruptions during therapy transportation and how addressing these in future updates is crucial for building greater resilience.
Creating this tool is just one of the many benefits of collaboration within the CGT Supply Chain workstream. We invite biomanufacturing and logistics industry representatives to join us for discussions, idea-sharing, and insights from top subject matter experts. Let’s work together to shape the future of CGT supply chains! Get in touch by emailing scott.clayton@biophorum.com and for more information about BioPhorum Supply Chain to Patient, visit our homepage.
Download the tool here.
United States
